NCT04072419

Brief Summary

The purpose of this prospective cohort study is to evaluate the safety and effectiveness of enhanced recovery after surgery (ERAS) to perform routine thoracoscopic repair for elective esophageal atresia type C

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Sep 2019

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 19, 2019

Completed
9 days until next milestone

First Posted

Study publicly available on registry

August 28, 2019

Completed
4 days until next milestone

Study Start

First participant enrolled

September 1, 2019

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 30, 2022

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2022

Completed
Last Updated

September 4, 2019

Status Verified

August 1, 2019

Enrollment Period

3 years

First QC Date

August 19, 2019

Last Update Submit

August 31, 2019

Conditions

Keywords

esophageal atresiaenhanced recovery after surgeryperioperative management

Outcome Measures

Primary Outcomes (4)

  • Number of participants with post-operative anastomotic leak

    Comparison of the morbidity of anastomotic leak between ERAS group and control group, including major and minor leaks

    one month after surgery

  • Number of participants with post-operative recurrent fistula

    Comparison of the morbidity of recurrent fistula between ERAS group and control group

    two years after surgery

  • Number of participants with post-operative anastomotic strictures

    Comparison of the morbidity of anastomotic strictures between ERAS group and control. Anastomotic strictures defined as there are symptoms which require intervention.

    two years after surgery

  • Total number of participants with post-operative complications

    Vocal cord dysfunction, Surgical site infection, Chylothorax, Gastroesophageal reflux, pleural effusion and other complications

    two years after surgery

Secondary Outcomes (2)

  • length of stay

    up to 24 weeks

  • Length of nutritional support in hospital

    up to 24 weeks

Study Arms (2)

enhanced recovery after surgery group

1. weaning mechanical ventilation after surgery (less than 48h), 2. no post-operative chest tube and urinary catheterization) 3. Establishment of early feeding (D3 post-operative)

control group

1. the time of mechanical ventilation after surgery is more than 48 hours 2. routine postoperative indwelling chest tube and urinary catheterization) 3. Establishment of feeding after D3 post-operative

Eligibility Criteria

Age1 Hour - 1 Month
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

The study population includes congenital esophageal atresia with type C present to Guangzhou Women and Children's Medical Center

You may qualify if:

  • congenital esophageal atresia with type C
  • the distance of blind end is less than 2.5cm
  • weight\>2.4Kg
  • without related malformations (heart, kidney),
  • without structural heart disease (excluding patent ductus arteriosus, patent foramen ovale, or atrial septal defect)

You may not qualify if:

  • Type A/B/D/E esophageal atresia
  • the distance of blind end is more than 2.5cm
  • weight is less than 2.4Kg
  • with Inherited chromosomal related diseases
  • with congenital heart disease (excluding patent ductus arteriosus, patent foramen ovale, or atrial septal defect)
  • preoperative severe pneumonia need mechanical ventilation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Guangzhou Women and Children's Medical Cente

Guangzhou, China

RECRUITING

MeSH Terms

Conditions

Esophageal Atresia

Condition Hierarchy (Ancestors)

Digestive System AbnormalitiesDigestive System DiseasesEsophageal DiseasesGastrointestinal DiseasesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Central Study Contacts

Qiuming He, Doctor

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Department of Neonatal Surgery of vice director doctor

Study Record Dates

First Submitted

August 19, 2019

First Posted

August 28, 2019

Study Start

September 1, 2019

Primary Completion

August 30, 2022

Study Completion

December 30, 2022

Last Updated

September 4, 2019

Record last verified: 2019-08

Locations